Cadila group receives USFDA approval for Ranolazine Extended-Release
Zydus Cadila has received final USFDA approval to market generic Ranolazine Extended-Release tablets used for treatment of chronic angina in US markets. The company will […]
USFDA
Unichem Laboratories receives USFDA approval for Chlorthalidone
Unichem Laboratories has received USFDA approval to market Chlorthalidone tablets in USA. The prescribed drug is used to treat high blood pressure. It will be […]
Alembic Pharma receives USFDA approval for Pregabalin
Alembic Pharmaceuticals has received USFDA approval for Pregabalin Capsules, indicated for management of neuropathic pain associated with certain illnesses. The drug is a therapeutically equivalent […]
Glenmark Pharma receives USFDA approval for Ranolazine tablets
Glenmark Pharma has received final USFDA approval for its Ranolazine extended-release tablets used for treatment of chronic angina. The drug Ranolazine extended-release tablets will be […]
Glenmark Pharma receives USFDA approval for Ezetimibe
Glenmark Pharmaceuticals has received final USFDA approval for Ezetimibe and Simvastatin tablets, used for treating high levels of cholesterol in the blood. The approved product […]
Alembic Pharma receives USFDA approval for Clonazepam
Alembic Pharmaceuticals has received USFDA approval for Clonazepam orally disintegrating tablets which are used for treatment of seizures, adjunct in the treatment of the Lennox-Gastaut […]
Alembic Pharma receives USFDA approval for Bromfenac Ophthalmic Solution
Alembic Pharmaceuticals has received USFDA approval from for Bromfenac Ophthalmic Solution, used for treatment of post-operative inflammation and reduction of ocular pain in patients who […]
Alembic Pharma receives USFDA approval for Oseltamivir Phosphate
Alembic Pharmaceuticals has received final USFDA approval for Oseltamivir Phosphate capsules, used for treatment of influenza infection. The drug is therapeutically equivalent to the reference […]
Glenmark Pharma receives USFDA approval for Solifenacin Succinate
Glenmark has receive final USFDA approval for Solifenacin Succinate Tablets in strengths of 5 mg and 10 mg. The drug Solifenacin Succinate is a generic […]
Alembic Pharma receives USFDA approval for Solifenacin Succinate
Alembic Pharmaceuticals has received USFDA approval for Solifenacin Succinate tablets which are used for treatment of over-active bladder. The product Solifenacin Succinate is a generic […]